EDITOR: | April 9th, 2014

Affinor Resources Attracts Experienced Plant Geneticist and Plant Molecular Biologist, Dr. Hyder A. Khoja to the Advisory Board

| April 09, 2014 | No Comments

April 9, 2014 (Source: Marketwired) — Affinor Resources (CSE:AFI) increases its strength in the medical marijuana market by adding to its advisory board, world renowned scientist Hyder A. Khoja, Ph.D., M.Sc., A.Ag.

Dr. Hyder A. Khoja is highly growth focused individual with over 17 years of extensive experience in a broad range of life sciences with strong leadership combined with functional expertise and experience in general business management.

He brings in a strong adaptive ability in leading diverse regulatory program areas, and solid experience both in science and policy domains. His industry experience spans from initiation, operation, and contribution towards developing several research and business proposals in the fields of Agriculture-Food Security, Food Safety & Sovereignty, Alternative energy, Renewable resources, Biofuels, Nutraceutical, Hydroponics, Agriculture & Land use management and Technology transfer. He held multiple positions in USA, where he dealt business and research operations. While working at the Center of Excellence for Hazardous Materials Management, NM-USA, he built a foundation of strong cross-functional skills including marketing, finance, business development, and operations with successful Algae for Energy (biofuel project) grant from US-Department of Energy for over US $23 million. He adopts a values-based philosophy to successfully lead multidisciplinary teams of planning and management groups from (professionals-biologists, engineers, planners and scientists) which results in achieving goals and consistent delivery of a broad range of products in a timely fashion.

Dr. Khoja holds his doctorate in Cellular & Molecular Biology and M.Sc., in Plant Biotechnology and Genetic Engineering from the Institute National Polytechnique (Ecole National Supérieure Agronomique de Toulouse, France; and Sindh Agriculture University, TandoJam-Pakistan respectively. He received his post-doctoral training from Michigan State University-DOE Plant Research Laboratory. In his past tenure he served as a Research Faculties at Virginia Tech, University of Wyoming, and Texas Tech Health Sci. Center; where he demonstrated an “Out-of-Box” approach for Research and product development. He has presented his work both in at federal government and academic institutions with authorship in over 18 peer-reviewed papers, primarily in Genomics, Plant breeding & Genetics and alternative energy. His work was also recognized and appeared in United Nations Food and Agriculture Organization (FAO) Environment and Natural Resources Management as a working paper for Algae-based Biofuels. He is an honor roll runner, and currently pursuing his online executive MBA from Harvard business school. The company has granted 100,000 incentive stock options to Dr. Khoja to purchase common shares of the company. The options are exercisable on or before April 9, 2019 at an exercise price of $0.25 per share.

Sebastien Plouffe, President and CEO of Affinor Resources comments: “I am very pleased to the great addition of Dr. Khoja to our advisory board. The list of Excellence Awards, Scholarships, Gold Medal Awards and Honor Shields bestowed on Dr. Khoja is exhaustive. His brilliance will bring an undisputable edge to Affinor Resources in their move to becoming a premier Canadian Medical Marijuana and Industrial Hemp producer with plans to be trading on the OTC and the Marijuana Exchange very soon.”

About Affinor Resources Inc.

Affinor Resources is a diversified publicly traded company on the Canadian Securities Exchange under the symbol (“AFI”). Affinor is focused on the Medical Marijuana industry within North America as well as Affinor has a Mineral Exploration division. Affinor is currently working towards becoming a premier Canadian Medical Marijuana and Industrial Hemp company by consolidating fragmented medical marijuana grower facilities and bringing industry expertise to its advisory board.

On Behalf of the Board of Directors


“Sebastien Plouffe”

President & CEO

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release


This News Release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This News Release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.


Raj Shah has been a member of the InvestorIntel.com team for the last nearly 9 years. Recruited from Merrill Lynch, he has over 13 years’ ... <Read more about Raj Shah>

Copyright © 2021 InvestorIntel Corp. All rights reserved. More & Disclaimer »

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.